Perseus Proteomics Inc. (4882.T)

JPY 610.0

(-0.65%)

Gross Profit Summary of Perseus Proteomics Inc.

  • Perseus Proteomics Inc.'s latest annual gross profit in 2023 was 87.68 Million JPY , up 1.33% from previous year.
  • Perseus Proteomics Inc.'s latest quarterly gross profit in 2024 Q1 was 19.34 Million JPY , down -13.47% from previous quarter.
  • Perseus Proteomics Inc. reported a annual gross profit of 86.53 Million JPY in annual gross profit 2022, up 27.73% from previous year.
  • Perseus Proteomics Inc. reported a annual gross profit of 67.74 Million JPY in annual gross profit 2021, up 5.69% from previous year.
  • Perseus Proteomics Inc. reported a quarterly gross profit of 22.46 Million JPY for 2023 Q2, down -3.36% from previous quarter.
  • Perseus Proteomics Inc. reported a quarterly gross profit of 23.24 Million JPY for 2023 Q1, up 14.42% from previous quarter.

Annual Gross Profit Chart of Perseus Proteomics Inc. (2023 - 2019)

Historical Annual Gross Profit of Perseus Proteomics Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 87.68 Million JPY 1.33%
2022 86.53 Million JPY 27.73%
2021 67.74 Million JPY 5.69%
2020 64.1 Million JPY -18.86%
2019 79 Million JPY 0.0%

Peer Gross Profit Comparison of Perseus Proteomics Inc.

Name Gross Profit Gross Profit Difference
Kyowa Kirin Co., Ltd. 320.62 Billion JPY 99.973%
Astellas Pharma Inc. 1212.36 Billion JPY 99.993%
Chugai Pharmaceutical Co., Ltd. 693 Billion JPY 99.987%
Ono Pharmaceutical Co., Ltd. 375.54 Billion JPY 99.977%
Santen Pharmaceutical Co., Ltd. 163.87 Billion JPY 99.946%
JCR Pharmaceuticals Co., Ltd. 31.25 Billion JPY 99.719%
Daiichi Sankyo Company, Limited 1181.79 Billion JPY 99.993%
Otsuka Holdings Co., Ltd. 1407.34 Billion JPY 99.994%